For individuals receiving B12 injections for severe deficiency, there have been isolated reports of hypokalaemia (low potassium) during initial treatment, as rapid cell production consumes potassium
Over weeks of dosing, those small errors compound
Nanoparticle and Exosome-Based Carrier : Nanoparticles and engineered exosomes can encapsulate therapeutics and be functionalized with BBB-targeting ligands (e.g., transferrin or LRP1)
This can cause tiredness, weakness, and shortness of breath
The key mechanistic evidence: pre-treatment with L-NAME (N-Nitro-L-arginine methyl ester, a non-selective NOS inhibitor) or L-NMMA (a selective eNOS inhibitor) abolishes BPC-157s angiogenic effect in wound models CD31+ microvessel density in BPC-157 + L-NAME groups returns to vehicle-equivalent levels
These growth elementsplay pivotal roles in tissue repair and regeneration